After excluding thymoma—seen in 10% of all AChR-MG patients-, the AChR-positive MG patients respond to pyridostigmine (an acetyl-cholinesterase inhibitor) followed by steroids and a steroid-sparing immunosuppressant such as azathioprine or most preferably today mycophenolate. Here, ACHE is linked to myasthenia gravis.